Currently holds positions in Oncopeptides AB and Gilead Sciences Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Oncopeptides AB | May 17, 2018 - |
Independent Director | Gilead Sciences Inc | Jan. 28, 2010 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-24 | 2024-04-19 |
Oncopeptides AB
(ONCO)
|
B Purchase |
204,664
2.60532,126 SEK |
204,664 | 2.60 | 532,126 SEK | |
2024-04-19 | 2024-04-19 |
Oncopeptides AB
(ONCO)
|
B Purchase |
204,664
2.60532,126 SEK |
204,664 | 2.60 | 532,126 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
1,000
27.1627,160 SEK |
1,000 | 27.16 | 27,160 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
250
27.136,783 SEK |
250 | 27.13 | 6,783 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
115
27.103,117 SEK |
115 | 27.10 | 3,117 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
500
27.0913,545 SEK |
500 | 27.09 | 13,545 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
480
26.9512,936 SEK |
480 | 26.95 | 12,936 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
176
26.954,743 SEK |
176 | 26.95 | 4,743 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
600
26.8916,134 SEK |
600 | 26.89 | 16,134 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
443
27.0011,961 SEK |
443 | 27.00 | 11,961 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
20
27.00540 SEK |
20 | 27.00 | 540 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
2,050
27.0055,350 SEK |
2,050 | 27.00 | 55,350 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
1,702
26.9445,852 SEK |
1,702 | 26.94 | 45,852 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
1,211
26.9332,612 SEK |
1,211 | 26.93 | 32,612 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
2,000
26.9253,840 SEK |
2,000 | 26.92 | 53,840 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
1,000
26.9126,910 SEK |
1,000 | 26.91 | 26,910 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
20
26.90538 SEK |
20 | 26.90 | 538 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
1,700
26.9045,730 SEK |
1,700 | 26.90 | 45,730 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
B Purchase |
1,029
26.8927,670 SEK |
1,029 | 26.89 | 27,670 SEK | |
2022-01-12 | 2022-01-12 |
Oncopeptides AB
(ONCO)
|
B Purchase |
185,540
7.601,410,898 SEK |
185,540 | 7.60 | 1,410,898 SEK | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
S Sale |
6,600
-3.7%
35.08231,528 USD |
6,600 -3.7% | 35.08 | 231,528 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
S Sale |
3,600
-2.0%
35.05126,180 USD |
3,600 -2.0% | 35.05 | 126,180 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
S Sale |
24,800
-11.9%
35.03868,744 USD |
24,800 -11.9% | 35.03 | 868,744 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
S Sale |
35,000
-14.4%
35.011,225,350 USD |
35,000 -14.4% | 35.01 | 1,225,350 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
S Sale |
24,949
-9.3%
35.00873,215 USD |
24,949 -9.3% | 35.00 | 873,215 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
S Sale |
7,500
-4.2%
45.19338,925 USD |
7,500 -4.2% | 45.19 | 338,925 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
S Sale |
5,000
-2.7%
45.18225,900 USD |
5,000 -2.7% | 45.18 | 225,900 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
S Sale |
15,000
-7.5%
45.13676,950 USD |
15,000 -7.5% | 45.13 | 676,950 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
S Sale |
7,500
-3.6%
45.10338,250 USD |
7,500 -3.6% | 45.10 | 338,250 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
S Sale |
5,000
-2.3%
45.04225,200 USD |
5,000 -2.3% | 45.04 | 225,200 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
S Sale |
16,400
-7.2%
45.03738,492 USD |
16,400 -7.2% | 45.03 | 738,492 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
S Sale |
10,000
-4.2%
45.20452,000 USD |
10,000 -4.2% | 45.20 | 452,000 USD |